Iron Hills Therapeutics
Andover, US · Founded 2020 · Delaware corporation
Founders & leadership
TM
Thomas MalcolmNamed on SEC filing
DR
David RoweNamed on SEC filing
MM
Michael MartinoNamed on SEC filing
LK
Llew KeltnerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2020–2022
▶$1.7MraisedMar 2022 · 12 investors · BiotechnologyRule 506(b)
▶$1.7MraisedMar 2022 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MartinoDirector
- Thomas MalcolmExecutive Officer, Director
- Jeffrey RileyExecutive Officer, Director
- Llew KeltnerDirector
- Offering amount
- $5M
- Amount sold
- $1.7M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$390KraisedDec 2020 · 9 investors · Other Health CareRule 506(b)
▶$390KraisedDec 2020 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas MalcolmExecutive Officer, Director
- David RoweExecutive Officer
- Michael MartinoDirector
- Llew KeltnerDirector
- Offering amount
- $550K
- Amount sold
- $390K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Iron Hills Therapeutics raised?
- Iron Hills Therapeutics has disclosed $2.1M raised across 2 rounds.
- Where is Iron Hills Therapeutics headquartered?
- Iron Hills Therapeutics is headquartered in Andover, US.